Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
- PMID: 20159883
- DOI: 10.1093/humupd/dmq001
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
Abstract
BACKGROUND Polycystic ovary syndrome (PCOS) is a common condition in reproductive-aged women associated with impaired glucose tolerance (IGT), type 2 diabetes mellitus (DM2) and the metabolic syndrome. METHODS A literature search was conducted (MEDLINE, CINAHL, EMBASE, clinical trial registries and hand-searching) identifying studies reporting prevalence or incidence of IGT, DM2 or metabolic syndrome in women with and without PCOS. Data were presented as odds ratio (OR) [95% confidence interval (CI)] with fixed- and random-effects meta-analysis by Mantel-Haenszel methods. Quality testing was based on Newcastle-Ottawa Scaling and The Cochrane Collaboration's risk of bias assessment tool. Literature searching, data abstraction and quality appraisal were performed by two investigators. RESULTS A total of 2192 studies were reviewed and 35 were selected for final analysis. Women with PCOS had increased prevalence of IGT (OR 2.48, 95% CI 1.63, 3.77; BMI-matched studies OR 2.54, 95% CI 1.44, 4.47), DM2 (OR 4.43, 95% CI 4.06, 4.82; BMI-matched studies OR 4.00, 95% CI 1.97, 8.10) and metabolic syndrome (OR 2.88, 95% CI 2.40, 3.45; BMI-matched studies OR 2.20, 95% CI 1.36, 3.56). One study assessed IGT/DM2 incidence and reported no significant differences in DM2 incidence (OR 2.07, 95% CI 0.68, 6.30). One study assessed conversion from normal glucose tolerance to IGT/DM2 (OR 2.4, 95% CI 0.7, 8.0). No studies reported metabolic syndrome incidence. CONCLUSIONS Women with PCOS had an elevated prevalence of IGT, DM2 and metabolic syndrome in both BMI and non-BMI-matched studies. Few studies have determined IGT/DM2 or metabolic syndrome incidence in women with and without PCOS and further research is required.
Similar articles
-
Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression.Hum Reprod Update. 2018 Jul 1;24(4):455-467. doi: 10.1093/humupd/dmy007. Hum Reprod Update. 2018. PMID: 29590375
-
Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.J Obstet Gynaecol Can. 2019 Oct;41(10):1453-1460. doi: 10.1016/j.jogc.2018.11.026. Epub 2019 Feb 1. J Obstet Gynaecol Can. 2019. PMID: 30712903
-
Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.Fertil Steril. 2014 Apr;101(4):1123-8.e1. doi: 10.1016/j.fertnstert.2013.12.050. Epub 2014 Feb 4. Fertil Steril. 2014. PMID: 24502891 Clinical Trial.
-
Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.Nutr Res Rev. 2017 Jun;30(1):97-105. doi: 10.1017/S0954422416000287. Epub 2017 Feb 22. Nutr Res Rev. 2017. PMID: 28222828 Review.
-
Prevention of type 2 diabetes mellitus in polycystic ovary syndrome: A review.Diabetes Metab Syndr. 2017 Dec;11 Suppl 2:S913-S917. doi: 10.1016/j.dsx.2017.07.015. Epub 2017 Jul 8. Diabetes Metab Syndr. 2017. PMID: 28711517 Review.
Cited by
-
Correlation between thyroid hormone sensitivity and the risk of polycystic ovary syndrome.BMC Endocr Disord. 2024 May 30;24(1):76. doi: 10.1186/s12902-024-01607-3. BMC Endocr Disord. 2024. PMID: 38816692 Free PMC article.
-
Is the MIND diet useful for polycystic ovary syndrome? A case-control study.BMC Womens Health. 2024 May 9;24(1):282. doi: 10.1186/s12905-024-03090-3. BMC Womens Health. 2024. PMID: 38724955 Free PMC article.
-
Stress responses to bacterial and viral mimetics in polycystic ovary syndrome model rats.Brain Behav Immun Health. 2024 Apr 9;38:100772. doi: 10.1016/j.bbih.2024.100772. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38650845 Free PMC article.
-
Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease.Curr Cardiol Rep. 2024 Jun;26(6):483-495. doi: 10.1007/s11886-024-02050-5. Epub 2024 Apr 3. Curr Cardiol Rep. 2024. PMID: 38568339 Review.
-
Prevalence and Clinical Management of Adrenal Tumour-Related Hyperandrogenism: A Narrative Review.Life (Basel). 2024 Mar 9;14(3):360. doi: 10.3390/life14030360. Life (Basel). 2024. PMID: 38541685 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical